Global Primary Biliary Cirrhosis Drug Market Insights, Forecast to 2028

Table Of Contents

1 Study Coverage

1.1 Primary Biliary Cirrhosis Drug Product Introduction 1.2 Market by Type 1.2.1 Global Primary Biliary Cirrhosis Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Budesonide 1.2.3 FFP-104 1.2.4 GSK-2330672 1.2.5 MBX-8025 1.2.6 NGM-282 1.2.7 Others 1.3 Market by Application 1.3.1 Global Primary Biliary Cirrhosis Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Clinic 1.3.3 Hospital 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered2 Executive Summary 2.1 Global Primary Biliary Cirrhosis Drug Sales Estimates and Forecasts 2017-2028 2.2 Global Primary Biliary Cirrhosis Drug Revenue Estimates and Forecasts 2017-2028 2.3 Global Primary Biliary Cirrhosis Drug Revenue by Region: 2017 VS 2021 VS 2028 2.4 Global Primary Biliary Cirrhosis Drug Sales by Region 2.4.1 Global Primary Biliary Cirrhosis Drug Sales by Region (2017-2022) 2.4.2 Global Sales Primary Biliary Cirrhosis Drug by Region (2023-2028) 2.5 Global Primary Biliary Cirrhosis Drug Revenue by Region 2.5.1 Global Primary Biliary Cirrhosis Drug Revenue by Region (2017-2022) 2.5.2 Global Primary Biliary Cirrhosis Drug Revenue by Region (2023-2028) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa3 Competition by Manufacturers 3.1 Global Primary Biliary Cirrhosis Drug Sales by Manufacturers 3.1.1 Global Top Primary Biliary Cirrhosis Drug Manufacturers by Sales (2017-2022) 3.1.2 Global Primary Biliary Cirrhosis Drug Sales Market Share by Manufacturers (2017-2022) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Primary Biliary Cirrhosis Drug in 2021 3.2 Global Primary Biliary Cirrhosis Drug Revenue by Manufacturers 3.2.1 Global Primary Biliary Cirrhosis Drug Revenue by Manufacturers (2017-2022) 3.2.2 Global Primary Biliary Cirrhosis Drug Revenue Market Share by Manufacturers (2017-2022) 3.2.3 Global Top 10 and Top 5 Companies by Primary Biliary Cirrhosis Drug Revenue in 2021 3.3 Global Primary Biliary Cirrhosis Drug Sales Price by Manufacturers (2017-2022) 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Primary Biliary Cirrhosis Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Primary Biliary Cirrhosis Drug Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans4 Market Size by Type 4.1 Global Primary Biliary Cirrhosis Drug Sales by Type 4.1.1 Global Primary Biliary Cirrhosis Drug Historical Sales by Type (2017-2022) 4.1.2 Global Primary Biliary Cirrhosis Drug Forecasted Sales by Type (2023-2028) 4.1.3 Global Primary Biliary Cirrhosis Drug Sales Market Share by Type (2017-2028) 4.2 Global Primary Biliary Cirrhosis Drug Revenue by Type 4.2.1 Global Primary Biliary Cirrhosis Drug Historical Revenue by Type (2017-2022) 4.2.2 Global Primary Biliary Cirrhosis Drug Forecasted Revenue by Type (2023-2028) 4.2.3 Global Primary Biliary Cirrhosis Drug Revenue Market Share by Type (2017-2028) 4.3 Global Primary Biliary Cirrhosis Drug Price by Type 4.3.1 Global Primary Biliary Cirrhosis Drug Price by Type (2017-2022) 4.3.2 Global Primary Biliary Cirrhosis Drug Price Forecast by Type (2023-2028)5 Market Size by Application 5.1 Global Primary Biliary Cirrhosis Drug Sales by Application 5.1.1 Global Primary Biliary Cirrhosis Drug Historical Sales by Application (2017-2022) 5.1.2 Global Primary Biliary Cirrhosis Drug Forecasted Sales by Application (2023-2028) 5.1.3 Global Primary Biliary Cirrhosis Drug Sales Market Share by Application (2017-2028) 5.2 Global Primary Biliary Cirrhosis Drug Revenue by Application 5.2.1 Global Primary Biliary Cirrhosis Drug Historical Revenue by Application (2017-2022) 5.2.2 Global Primary Biliary Cirrhosis Drug Forecasted Revenue by Application (2023-2028) 5.2.3 Global Primary Biliary Cirrhosis Drug Revenue Market Share by Application (2017-2028) 5.3 Global Primary Biliary Cirrhosis Drug Price by Application 5.3.1 Global Primary Biliary Cirrhosis Drug Price by Application (2017-2022) 5.3.2 Global Primary Biliary Cirrhosis Drug Price Forecast by Application (2023-2028)6 North America 6.1 North America Primary Biliary Cirrhosis Drug Market Size by Type 6.1.1 North America Primary Biliary Cirrhosis Drug Sales by Type (2017-2028) 6.1.2 North America Primary Biliary Cirrhosis Drug Revenue by Type (2017-2028) 6.2 North America Primary Biliary Cirrhosis Drug Market Size by Application 6.2.1 North America Primary Biliary Cirrhosis Drug Sales by Application (2017-2028) 6.2.2 North America Primary Biliary Cirrhosis Drug Revenue by Application (2017-2028) 6.3 North America Primary Biliary Cirrhosis Drug Market Size by Country 6.3.1 North America Primary Biliary Cirrhosis Drug Sales by Country (2017-2028) 6.3.2 North America Primary Biliary Cirrhosis Drug Revenue by Country (2017-2028) 6.3.3 U.S. 6.3.4 Canada7 Europe 7.1 Europe Primary Biliary Cirrhosis Drug Market Size by Type 7.1.1 Europe Primary Biliary Cirrhosis Drug Sales by Type (2017-2028) 7.1.2 Europe Primary Biliary Cirrhosis Drug Revenue by Type (2017-2028) 7.2 Europe Primary Biliary Cirrhosis Drug Market Size by Application 7.2.1 Europe Primary Biliary Cirrhosis Drug Sales by Application (2017-2028) 7.2.2 Europe Primary Biliary Cirrhosis Drug Revenue by Application (2017-2028) 7.3 Europe Primary Biliary Cirrhosis Drug Market Size by Country 7.3.1 Europe Primary Biliary Cirrhosis Drug Sales by Country (2017-2028) 7.3.2 Europe Primary Biliary Cirrhosis Drug Revenue by Country (2017-2028) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia8 Asia Pacific 8.1 Asia Pacific Primary Biliary Cirrhosis Drug Market Size by Type 8.1.1 Asia Pacific Primary Biliary Cirrhosis Drug Sales by Type (2017-2028) 8.1.2 Asia Pacific Primary Biliary Cirrhosis Drug Revenue by Type (2017-2028) 8.2 Asia Pacific Primary Biliary Cirrhosis Drug Market Size by Application 8.2.1 Asia Pacific Primary Biliary Cirrhosis Drug Sales by Application (2017-2028) 8.2.2 Asia Pacific Primary Biliary Cirrhosis Drug Revenue by Application (2017-2028) 8.3 Asia Pacific Primary Biliary Cirrhosis Drug Market Size by Region 8.3.1 Asia Pacific Primary Biliary Cirrhosis Drug Sales by Region (2017-2028) 8.3.2 Asia Pacific Primary Biliary Cirrhosis Drug Revenue by Region (2017-2028) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 8.3.12 Philippines9 Latin America 9.1 Latin America Primary Biliary Cirrhosis Drug Market Size by Type 9.1.1 Latin America Primary Biliary Cirrhosis Drug Sales by Type (2017-2028) 9.1.2 Latin America Primary Biliary Cirrhosis Drug Revenue by Type (2017-2028) 9.2 Latin America Primary Biliary Cirrhosis Drug Market Size by Application 9.2.1 Latin America Primary Biliary Cirrhosis Drug Sales by Application (2017-2028) 9.2.2 Latin America Primary Biliary Cirrhosis Drug Revenue by Application (2017-2028) 9.3 Latin America Primary Biliary Cirrhosis Drug Market Size by Country 9.3.1 Latin America Primary Biliary Cirrhosis Drug Sales by Country (2017-2028) 9.3.2 Latin America Primary Biliary Cirrhosis Drug Revenue by Country (2017-2028) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina10 Middle East and Africa 10.1 Middle East and Africa Primary Biliary Cirrhosis Drug Market Size by Type 10.1.1 Middle East and Africa Primary Biliary Cirrhosis Drug Sales by Type (2017-2028) 10.1.2 Middle East and Africa Primary Biliary Cirrhosis Drug Revenue by Type (2017-2028) 10.2 Middle East and Africa Primary Biliary Cirrhosis Drug Market Size by Application 10.2.1 Middle East and Africa Primary Biliary Cirrhosis Drug Sales by Application (2017-2028) 10.2.2 Middle East and Africa Primary Biliary Cirrhosis Drug Revenue by Application (2017-2028) 10.3 Middle East and Africa Primary Biliary Cirrhosis Drug Market Size by Country 10.3.1 Middle East and Africa Primary Biliary Cirrhosis Drug Sales by Country (2017-2028) 10.3.2 Middle East and Africa Primary Biliary Cirrhosis Drug Revenue by Country (2017-2028) 10.3.3 Turkey 10.3.4 Saudi Arabia11 Company Profiles 11.1 AlbireoPharma 11.1.1 AlbireoPharma Corporation Information 11.1.2 AlbireoPharma Overview 11.1.3 AlbireoPharma Primary Biliary Cirrhosis Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.1.4 AlbireoPharma Primary Biliary Cirrhosis Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 AlbireoPharma Recent Developments 11.2 CymaBay Therapeutics, Inc. 11.2.1 CymaBay Therapeutics, Inc. Corporation Information 11.2.2 CymaBay Therapeutics, Inc. Overview 11.2.3 CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.2.4 CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 CymaBay Therapeutics, Inc. Recent Developments 11.3 Dr. Falk Pharma GmbH 11.3.1 Dr. Falk Pharma GmbH Corporation Information 11.3.2 Dr. Falk Pharma GmbH Overview 11.3.3 Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.3.4 Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 Dr. Falk Pharma GmbH Recent Developments 11.4 Enanta Pharmaceuticals, Inc. 11.4.1 Enanta Pharmaceuticals, Inc. Corporation Information 11.4.2 Enanta Pharmaceuticals, Inc. Overview 11.4.3 Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.4.4 Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 Enanta Pharmaceuticals, Inc. Recent Developments 11.5 GlaxoSmithKline Plc 11.5.1 GlaxoSmithKline Plc Corporation Information 11.5.2 GlaxoSmithKline Plc Overview 11.5.3 GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.5.4 GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.5.5 GlaxoSmithKline Plc Recent Developments 11.6 Intercept Pharmaceuticals, Inc. 11.6.1 Intercept Pharmaceuticals, Inc. Corporation Information 11.6.2 Intercept Pharmaceuticals, Inc. Overview 11.6.3 Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.6.4 Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.6.5 Intercept Pharmaceuticals, Inc. Recent Developments 11.7 Johnson & Johnson 11.7.1 Johnson & Johnson Corporation Information 11.7.2 Johnson & Johnson Overview 11.7.3 Johnson & Johnson Primary Biliary Cirrhosis Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.7.4 Johnson & Johnson Primary Biliary Cirrhosis Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.7.5 Johnson & Johnson Recent Developments 11.8 MediGene AG 11.8.1 MediGene AG Corporation Information 11.8.2 MediGene AG Overview 11.8.3 MediGene AG Primary Biliary Cirrhosis Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.8.4 MediGene AG Primary Biliary Cirrhosis Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.8.5 MediGene AG Recent Developments 11.9 NGM Biopharmaceuticals, Inc. 11.9.1 NGM Biopharmaceuticals, Inc. Corporation Information 11.9.2 NGM Biopharmaceuticals, Inc. Overview 11.9.3 NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.9.4 NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.9.5 NGM Biopharmaceuticals, Inc. Recent Developments 11.10 Virobay Inc. 11.10.1 Virobay Inc. Corporation Information 11.10.2 Virobay Inc. Overview 11.10.3 Virobay Inc. Primary Biliary Cirrhosis Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.10.4 Virobay Inc. Primary Biliary Cirrhosis Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.10.5 Virobay Inc. Recent Developments12 Industry Chain and Sales Channels Analysis 12.1 Primary Biliary Cirrhosis Drug Industry Chain Analysis 12.2 Primary Biliary Cirrhosis Drug Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Primary Biliary Cirrhosis Drug Production Mode & Process 12.4 Primary Biliary Cirrhosis Drug Sales and Marketing 12.4.1 Primary Biliary Cirrhosis Drug Sales Channels 12.4.2 Primary Biliary Cirrhosis Drug Distributors 12.5 Primary Biliary Cirrhosis Drug Customers13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Primary Biliary Cirrhosis Drug Industry Trends 13.2 Primary Biliary Cirrhosis Drug Market Drivers 13.3 Primary Biliary Cirrhosis Drug Market Challenges 13.4 Primary Biliary Cirrhosis Drug Market Restraints14 Key Findings in The Global Primary Biliary Cirrhosis Drug Study15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer